So Belzutifan is this thing called a HIF-2α pseudo-inhibitor, meant for a type of kidney cancer called VHL-associated RCC. It’s supposed to cut down on the signals that make tumors love being low on oxygen. They give it to you in these 40 mg tablets, kind of like little shiny pills.
You’re supposed to take it once a day, but that’s 120 mg, which works out to three tablets. These bottles come with 90 tablets, so they should last you about a month if you take it like they tell you to. The main stuff in Belzutifan is part of a group of drugs called HIF-2α inhibitors.
These guys go after a protein that helps cancer cells live and thrive when there’s not enough oxygen around. It’s a prescription pill, so you got to take it with the help of a doc or something. Oh, and there could be some not-so-nice stuff going on, so your doc will keep an eye on you for any side effects.
Reviews
There are no reviews yet.